Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker.

Aging (Albany NY) · 2020 · PMC7803585 · PMID 33221769

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Furthermore, a clear trend of higher MTIs activities was observed in DYNC1H1-mutated GC cells ( Supplementary Figure 4 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.